CompletedPhase 3NCT01092962
Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children
Studying Idiopathic nephrotic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Véronique BAUDOUIN, MDAssistance Publique - Hôpitaux de Paris
- Intervention
- Cyclophosphamide(drug)
- Enrollment
- 70 enrolled
- Eligibility
- 2-16 years · All sexes
- Timeline
- 2010 – 2015
Study locations (1)
- Robert Debre Hospital, AP-HP, Paris, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01092962 on ClinicalTrials.govOther trials for Idiopathic nephrotic syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06820866Non-invasive Diagnosis of Idiopathic Nephrotic SyndromesAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE3NCT05627557A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic SyndromeHoffmann-La Roche
- RECRUITINGNCT04207580A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.University Hospital, Limoges